Madison Square Garden Sports Corp (MSGS) Stock Price, Quote & News

Company Profile

Madison Square Garden Sports Corp. operates as a professional sports company in the United States. The company owns and operates a portfolio of assets that consists of the New York Knickerbockers of the National Basketball Association (NBA) and the New York Rangers of the National Hockey League. Its other professional franchises include development league teams, the Hartford Wolf Pack of the American Hockey League and the Westchester Knicks of the NBA G League. It also operates the Madison Squar...

Industry: Entertainment

Sector: Communication Services

Phone: 212 465 4111

Website: www.msgsports.com

Address:

Two Pennsylvania Plaza, New York, United States

PrivateProfiteersAnalyst Dec. 25 at 3:06 PM

$MSGS: Current market context shows a strong bullish sentiment with the last close at $259.12. The RSI at 84.69 indicates overbought conditions, suggesting a potential pullback. However, the price is above both the 30-day MA (228.67) and 50-day MA (225.86), indicating overall upward momentum. Directional bias remains bullish, but caution is warranted due to the high RSI. The 60D high is $261.65, just above the current price, which could act as a resistance level. Trade Plan: - Suggested Entry: $259.12 - Stop Loss: $251.28 (approximately 3% below entry) - Take Profit Targets: - Target 1: $265.00 (2.24% gain) - Target 2: $270.00 (4.20% gain) - Target 3: $303.00 (17% gain) This plan allows for potential gains while managing risk effectively. Monitor RSI for signs of reversal before entering. https://privateprofiteers.com

0 · Reply

Doozio Dec. 23 at 10:00 PM

$MSGS dips are a 🎁 wen da huckleberries are thru da $$$ ENTA 🐒🍌🧠⏰♾️

0 · Reply

Tdorsey1776 Dec. 19 at 6:36 PM

$MSGS Is Dolan selling? I didnt think we'd move this much without a rumor of Dolan putting MSG on the block.

0 · Reply

PrivateProfiteersAnalyst Dec. 19 at 5:02 PM

$MSGS Trade Alert: Market Context: $MSGS is currently trading at $238.22, showing strength with an RSI of 63.4, indicating bullish momentum but nearing overbought territory. The price is above both the 30-day MA (224.05) and the 50-day MA (223.02), suggesting a positive trend. The recent high of $245.49 indicates potential resistance, while the 60-day low of $207.90 provides a solid support level. Directional Bias: Given the bullish indicators and the proximity to the recent high, we anticipate upward movement but recommend caution due to the RSI nearing overbought levels. Trade Plan: - Suggested Entry: $238.22 - Stop Loss: $225.00 (approximately 5.5% below entry) - Take Profit Targets: 1. $245.00 (2.9% gain) 2. $250.00 (4.9% gain) 3. $279.00 (17.1% gain) With this plan, we aim for a minimum of 17% ROI on the third target while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com

0 · Reply

PrivateProfiteersAnalyst Dec. 17 at 3:47 AM

$MSGS Actionable Trade Alert: Market Context: $MSGS is currently trading at $235.21, showing strength with an RSI of 66.37, indicating it is approaching overbought territory. The price is above both the 30-day MA (222.56) and 50-day MA (222.22), suggesting bullish momentum. The recent high of $243.71 is within reach, while the low of $207.90 provides a solid support level. Directional Bias: The bullish trend is supported by the price action above key moving averages, but caution is warranted due to the elevated RSI. Trade Plan: - Suggested Entry: $235.21 - Stop Loss: $228.00 (below recent support) - Take Profit Targets: 1. $240.00 (2% gain) 2. $245.00 (4.15% gain) 3. $275.00 (17% gain) This plan offers a potential ROI of over 17% on the third target, aligning with the market's upward momentum while managing risk effectively. https://privateprofiteers.com

0 · Reply

JarvisFlow Dec. 16 at 7:31 PM

Citigroup has adjusted their stance on Madison Square Garden ( $MSGS ), setting the rating to Buy with a target price of 285 → 290.

0 · Reply

JarvisFlow Dec. 15 at 4:19 PM

Wolfe Research has adjusted their stance on Madison Square Garden ( $MSGS ), setting the rating to Peer Perform.

0 · Reply

PrivateProfiteersAnalyst Dec. 15 at 7:20 AM

$MSGS: The stock closed at $237.44, showing strong upward momentum with an RSI of 78.13, indicating overbought conditions. The 30-day MA at $221.17 and the 50-day MA at $222.03 suggest bullish sentiment, as the price is significantly above these averages. The 60-day high of $243.71 presents a potential resistance level, while the low of $207.90 provides a solid support base. Actionable Trade Plan: - Suggested Entry: $237.44 - Stop Loss: $230.00 (approx. 3.1% risk) - Take Profit Targets: 1. Target 1: $240.00 (1.1% gain) 2. Target 2: $245.00 (3.2% gain) 3. Target 3: $250.00 (5.3% gain) To achieve at least a 17% ROI, focus on the long-term potential as the price approaches the 60D high. Monitor the RSI for signs of reversal. Maintain discipline with your stop loss to protect against sudden volatility. https://privateprofiteers.com

0 · Reply

PrivateProfiteersAnalyst Dec. 12 at 12:14 AM

$MSGS Trade Alert: Current market context shows a strong bullish momentum with the last close at $231.98 and an RSI of 76.3, indicating overbought conditions. The price is above both the 30-day MA of $220.64 and the 50-day MA of $221.87, reinforcing a bullish bias. However, the RSI suggests caution as it approaches overbought territory. Action Plan: - Suggested Entry: $231.00 (slightly below last close to ensure entry) - Stop Loss: $225.00 (to limit downside risk) - Take Profit Targets: 1. $235.00 (1.74% gain) 2. $240.00 (3.48% gain) 3. $272.00 (17.25% gain) The third target aligns with the potential for a breakout above the 60-day high of $235.92. Monitor the ATR of $5.02 for volatility considerations. This trade plan leverages current market conditions while maintaining a strategic approach to risk management. https://privateprofiteers.com

0 · Reply

PrivateProfiteersAnalyst Dec. 10 at 4:17 AM

$MSGS Actionable Trade Alert: Market Context: $MSGS is currently trading at $225.9, showing strength but also indicating overbought conditions with an RSI of 70.77. The stock is above its 30-day MA of 220.49 and 50-day MA of 221.88, suggesting bullish momentum. However, the RSI indicates caution as it approaches overbought territory. Directional Bias: The recent high of $235.92 suggests potential resistance, while the low of $207.9 provides a solid support range. Given the current price action, we anticipate a pullback or consolidation before a potential breakout. Trade Plan: - Suggested Entry: $225.9 - Stop Loss: $220.0 (risking approximately 2.6%) - Take Profit Targets: 1. $230.0 (2% ROI) 2. $235.0 (4% ROI) 3. $265.0 (17% ROI) The third target aligns with the high range, providing a strong upside potential. Monitor RSI for signs of reversal. https://privateprofiteers.com

0 · Reply

MSG Family of Companies and PwC Announce Multi-Year Partnership

MSGE SPHR

Dec 4, 2025, 10:30 AM EST - 21 days ago

Pellera Technologies Named an Official Partner of the New York Rangers

Dec 4, 2025, 10:30 AM EST - 21 days ago

PELLERA TECHNOLOGIES NAMED AN OFFICIAL PARTNER OF THE NEW YORK RANGERS

Oct 31, 2025, 7:30 AM EDT - 7 weeks ago

Madison Square Garden Sports Corp. Reports Fiscal 2026 First Quarter Results

Oct 27, 2025, 4:30 PM EDT - 2 months ago

Madison Square Garden Sports Corp. to Release Fiscal 2026 First Quarter Results

Oct 22, 2025, 2:30 AM EDT - 2 months ago

Investment firm president says this stock is 'gushing cash'

Sep 16, 2025, 10:00 AM EDT - 3 months ago

GAME 7 Named First-Ever Official Jersey Patch Partner of the New York Rangers

Sep 15, 2025, 10:00 AM EDT - 3 months ago

Rangers Announce Centennial Season Theme Nights and Initiatives Celebrating 100 Years of Franchise History

Sep 12, 2025, 12:25 PM EDT - 3 months ago

Madison Square Garden Sports: Knicks And Rangers On Wall Street

Aug 12, 2025, 12:56 PM EDT - 4 months ago

Madison Square Garden Sports Corp. (MSGS) Q4 2025 Earnings Conference Call Transcript

Aug 12, 2025, 7:30 AM EDT - 4 months ago

Madison Square Garden Sports Corp. Reports Fiscal 2025 Fourth Quarter and Full-Year Results

Aug 6, 2025, 9:00 AM EDT - 5 months ago

Madison Square Garden Sports Corp. to Host Fiscal 2025 Fourth Quarter and Year-End Conference Call

Jul 15, 2025, 3:06 PM EDT - 5 months ago

Verizon, MSGS stocks may be tariff-proof, says Regan Capital's Weinand

Jun 24, 2025, 8:00 AM EDT - 6 months ago

The Boyar Value Group Urges James Dolan to End the ‘Dolan Discount' at MSG Sports by Splitting the Knicks and Rangers into two Separately Publicly Traded Companies.

Jun 24, 2025, 3:00 AM EDT - 6 months ago

Madison Square Garden Sports: Lakers Sale Dangles Giant Meatball Over The Big Apple

Jun 3, 2025, 3:51 PM EDT - 7 months ago

Knicks Announce Coaching Change

May 2, 2025, 7:30 AM EDT - 8 months ago

MADISON SQUARE GARDEN SPORTS CORP. REPORTS FISCAL 2025 THIRD QUARTER RESULTS

Apr 28, 2025, 8:30 AM EDT - 8 months ago

Madison Square Garden Sports Corp. to Release Fiscal 2025 Third Quarter Results

Mar 6, 2025, 11:00 AM EST - 10 months ago

TRES AGAVES TEQUILA NAMED AN OFFICIAL SPONSOR OF THE NEW YORK RANGERS

Mar 5, 2025, 8:30 AM EST - 10 months ago

THE MSG FAMILY OF COMPANIES AND PEPSICO EXPAND MULTI-YEAR PARTNERSHIP

MSGE PEP SPHR

Feb 4, 2025, 1:40 PM EST - 11 months ago

Madison Square Garden Sports Corp. (MSGS) Q2 2025 Earnings Call Transcript

Feb 4, 2025, 7:30 AM EST - 11 months ago

MADISON SQUARE GARDEN SPORTS CORP. REPORTS FISCAL 2025 SECOND QUARTER RESULTS

Jan 28, 2025, 4:30 PM EST - 11 months ago

Madison Square Garden Sports Corp. to Host Fiscal 2025 Second Quarter Conference Call

Jan 14, 2025, 9:04 AM EST - 1 year ago

WATERLOO SPARKLING WATER NAMED AN OFFICIAL PARTNER OF THE NEW YORK RANGERS AND MADISON SQUARE GARDEN

MSGE

Jan 13, 2025, 12:07 PM EST - 1 year ago

Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth

COR COST DHR EL WST

Jan 6, 2025, 3:28 PM EST - 1 year ago

Optimum-MSGN Standoff Could Pressure MSG Networks' Finances: Analyst

SPHR

Nov 1, 2024, 7:30 AM EDT - 1 year ago

MADISON SQUARE GARDEN SPORTS CORP. REPORTS FISCAL 2025 FIRST QUARTER RESULTS

Oct 28, 2024, 9:00 AM EDT - 1 year ago

Madison Square Garden Sports Corp. to Release Fiscal 2025 First Quarter Results

Oct 10, 2024, 10:00 AM EDT - 1 year ago

NEW YORK RANGERS AND BENJAMIN MOORE RENEW AND EXPAND SIGNATURE MULTI-YEAR PARTNERSHIP

Oct 4, 2024, 9:00 AM EDT - 1 year ago

THE MSG FAMILY OF COMPANIES AND VERIZON EXPAND PARTNERSHIP, NAMING VERIZON THE OFFICIAL MOBILE WIRELESS PARTNER ACROSS THE COMPANIES' PORTFOLIO

MSGE SPHR VZ

Aug 13, 2024, 3:23 PM EDT - 1 year ago

Madison Square Garden Sports Corp. (MSGS) Q4 2024 Earnings Call Transcript

Aug 13, 2024, 7:30 AM EDT - 1 year ago

MADISON SQUARE GARDEN SPORTS CORP. REPORTS FISCAL 2024 FOURTH QUARTER AND FULL-YEAR RESULTS

Aug 7, 2024, 9:00 AM EDT - 1 year ago

Madison Square Garden Sports Corp. to Host Fiscal 2024 Fourth Quarter and Year-End Conference Call

Jul 18, 2024, 11:22 AM EDT - 1 year ago

Paris Olympics: 5 Sports-Related Stocks Going for Gold

BATRA CMCSA DKNG DKS MODG NKE

Jul 9, 2024, 4:15 PM EDT - 1 year ago

MSG SPORTS NAMES JAMAAL LESANECHIEF OPERATING OFFICER

May 2, 2024, 7:30 AM EDT - 1 year ago

MADISON SQUARE GARDEN SPORTS CORP. REPORTS FISCAL 2024 THIRD QUARTER RESULTS

Apr 26, 2024, 9:00 AM EDT - 1 year ago

Madison Square Garden Sports Corp. to Release Fiscal 2024 Third Quarter Results

Feb 6, 2024, 1:09 PM EST - 2 years ago

Madison Square Garden Sports Corp. (MSGS) Q2 2024 Earnings Call Transcript

Feb 6, 2024, 7:30 AM EST - 2 years ago

MADISON SQUARE GARDEN SPORTS CORP. REPORTS FISCAL 2024 SECOND QUARTER RESULTS

Jan 31, 2024, 4:10 PM EST - 2 years ago

Madison Square Garden Sports Corp. to Host Fiscal 2024 Second Quarter Conference Call

Jan 16, 2024, 7:41 PM EST - 2 years ago

Top 10 stocks to buy in 2024

AMD AMZN BABA BNTX CRWD CVX B

Dec 15, 2023, 11:44 AM EST - 2 years ago

Barron's Favorite 10 Stocks for 2024

BABA BNTX CVX B GOOG GOOGL HTZ

Nov 15, 2023, 2:39 AM EST - 2 years ago

Madison Square Garden Sports: Quarterly Double-Digit Net Sales Growth, And Not Expensive

Nov 13, 2023, 11:00 AM EST - 2 years ago

NEXEN TIRE NAMED OFFICIAL PARTNER OF THE NEW YORK RANGERS

Nov 2, 2023, 7:30 AM EDT - 2 years ago

MADISON SQUARE GARDEN SPORTS CORP. REPORTS FISCAL 2024 FIRST QUARTER RESULTS

Oct 27, 2023, 9:00 AM EDT - 2 years ago

Madison Square Garden Sports Corp. to Release Fiscal 2024 First Quarter Results

Oct 16, 2023, 11:00 AM EDT - 2 years ago

MUCINEX NAMED OFFICIAL COLD & FLU MEDICINE PARTNER OF THE NEW YORK RANGERS

Aug 28, 2023, 9:25 AM EDT - 2 years ago

Meta, Alphabet and 10 under-the-radar media stocks expected to soar

GOOG GOOGL META AMCX CCOI CNK CNSL

Aug 18, 2023, 8:16 AM EDT - 2 years ago

Madison Square Garden Sports Corp. (MSGS) Q4 2023 Earnings Call Transcript

Aug 17, 2023, 7:30 AM EDT - 2 years ago

MADISON SQUARE GARDEN SPORTS CORP. REPORTS FISCAL 2023 FOURTH QUARTER AND FULL-YEAR RESULTS

PrivateProfiteersAnalyst Dec. 25 at 3:06 PM

0 · Reply

Doozio Dec. 23 at 10:00 PM

$MSGS dips are a 🎁 wen da huckleberries are thru da $$$ ENTA 🐒🍌🧠⏰♾️

0 · Reply

Tdorsey1776 Dec. 19 at 6:36 PM

$MSGS Is Dolan selling? I didnt think we'd move this much without a rumor of Dolan putting MSG on the block.

0 · Reply

PrivateProfiteersAnalyst Dec. 19 at 5:02 PM

0 · Reply

PrivateProfiteersAnalyst Dec. 17 at 3:47 AM

0 · Reply

JarvisFlow Dec. 16 at 7:31 PM

Citigroup has adjusted their stance on Madison Square Garden ( $MSGS ), setting the rating to Buy with a target price of 285 → 290.

0 · Reply

JarvisFlow Dec. 15 at 4:19 PM

Wolfe Research has adjusted their stance on Madison Square Garden ( $MSGS ), setting the rating to Peer Perform.

0 · Reply

PrivateProfiteersAnalyst Dec. 15 at 7:20 AM

0 · Reply

PrivateProfiteersAnalyst Dec. 12 at 12:14 AM

0 · Reply

PrivateProfiteersAnalyst Dec. 10 at 4:17 AM

0 · Reply

PrivateProfiteersAnalyst Dec. 9 at 12:05 AM

$MSGS Trade Alert: Market Context: $MSGS is currently trading at $226.01, showing strong bullish momentum with an RSI of 73.1, indicating overbought conditions. The stock is above its 30-day MA of 220.56 and 50-day MA of 221.98, suggesting upward momentum. The recent 60-day high of 235.92 presents a potential resistance level. Directional Bias: Given the high RSI and proximity to the 60-day high, a pullback may occur; however, the overall trend remains bullish. Suggested Trade Plan: - Entry: $226.01 - Stop Loss: $221.00 (below the 50-day MA) - Take Profit Targets: 1. $230.00 (1.76% ROI) 2. $235.00 (3.95% ROI) 3. $265.00 (17.3% ROI) Monitor the stock closely for any signs of reversal or sustained momentum. Adjust stop loss as necessary to lock in profits. https://privateprofiteers.com

0 · Reply

BillionerOfKing Dec. 6 at 3:51 AM

$MSGS Current Stock Price: $226.20 Contracts to trade: $230 MSGS Dec 19 2025 Call Entry: $2.65 Exit: $5.29 ROI: 100% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

PrivateProfiteersAnalyst Dec. 6 at 3:05 AM

$MSGS Actionable Trade Alert: Market Context: $MSGS is currently trading at $224.1, showing strength with an RSI of 60.17, indicating bullish momentum but not overbought. The price is above the 30-day MA of 220.64 and the 50-day MA of 221.85, suggesting a positive trend. Directional Bias: The price is closer to the 60-day high of 235.92, indicating potential upside. The RSI supports a bullish outlook, while the ATR of 4.89 suggests reasonable volatility for trading. Trade Plan: - Suggested Entry: $224.1 - Stop Loss: $219.1 (below the 30-day MA) - Take Profit Targets: - TP1: $230.0 (2.6% gain) - TP2: $235.0 (4.9% gain) - TP3: $262.0 (17% gain) This plan allows for a structured approach with a strong potential ROI, leveraging current price action and technical indicators. https://privateprofiteers.com

0 · Reply

PrivateProfiteersAnalyst Dec. 5 at 10:39 PM

0 · Reply

Estimize Dec. 1 at 2:00 PM

Wall St is expecting 0.52 EPS for $MSGS Q2 [Reporting 02/10 BMO] http://www.estimize.com/intro/msgs?chart=historical&metric_name=eps&utm_co

0 · Reply

BTECHINV Nov. 13 at 1:41 AM

$ALT $XBI More like the Nolan Ryan of Cardiometabolic Medicine in my opinion, drafted 295th overall (12th round) from a small town in Texas (Alvin), where only the locals who had seen him pitch throughout his high school career as well as a few very astute scouts truly understood the HOF potential of his arm. 7 Career No-Hitters (#1 all time MLB) 5,714 Career K's (#1 all time MLB) .204 Batting Average allowed (#1 all time MLB) 1st Ballot Hall of Famer (98.8%, 491/497 votes) 1st Professional Athlete to sign a $1 M salary One very sharp New York Mets scout, Red Murff, reported back to the team in 1963: "the best arm I've seen in my life". He understood wildness could be tamed (analogous to Trial Design dose reduction/titration), whereas power and velocity were innate characteristics. BTW, the six idiot professional sports writers who did not vote for Ryan remind me of some of the pseudo-science clowns on ST. $MSGS $BATRA $NVO Disclosure: Long Altimmune (Pemvi), not medical/investment advice.

4 · Reply

Tdorsey1776 Nov. 6 at 4:40 PM

$MSGS Looking to buyback ~$205...COME to poppa

0 · Reply

erevnon Nov. 3 at 6:48 PM

JP Morgan maintains Madison Square Garden $MSGS at Overweight and raises the price target from $230 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

JarvisFlow Nov. 3 at 3:18 PM

JP Morgan has adjusted their stance on Madison Square Garden ( $MSGS ), setting the rating to Overweight with a target price of 230 → 240.

0 · Reply

BillionerOfKing Nov. 3 at 2:27 PM

$MSGS Current Stock Price: $214.50 Contracts to trade: $210 MSGS Nov 21 2025 Call Entry: $5.77 Exit: $11.52 ROI: 100% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

SPG565 Oct. 31 at 1:23 PM

$MSGS https://www.businesswire.com/news/home/20251031289106/en/Madison-Square-Garden-Sports-Corp.-Reports-Fiscal-2026-First-Quarter-Results

0 · Reply

Estimize Oct. 23 at 1:36 PM

Wall St is expecting -0.84 EPS for $MSGS Q1 [Reporting 10/31 BMO] http://www.estimize.com/intro/msgs?chart=historical&metric_name=eps&utm_c

0 · Reply

Market Cap	6.17B
Revenue (ttm)	1.04B
Net Income (ttm)	-22.44M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-2.16%
Debt to Equity Ratio	-0.99

Volume	97,000
Avg Vol	175,724
Day's Range	N/A - N/A
Shares Out	24.02M
Stochastic %K	92%
Beta	0.66
Analysts	Sell
Price Target	$264.80